Development and validation of an LC-MS/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer
Acta Chromatographica · 02.09.2024 · 36 (3) · 186-195
DOI: 10.1556/1326.2023.01129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Chromatographica, erschienen am 02.09.2024. Verfasst von Keyu Zhang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A novel doxorubicin hydrochloride liposome injection was prepared to reduce toxicity and side effects, as well as extend plasma half-life in the treatment of breast cancer. In this study, a rapid and sensitive bioanalytical method was developed and validated to characterize the pharmacokinetic profile of total and free doxorubicin in plasma of 3 Chinese patients after intravenous infusion of this injection. Plasma samples were prepared by protein precipitation for the determination of total doxorubicin, while solid phase extraction was used to determine free doxorubicin. After plasma sample pre-treatment, total and free concentrations were quantified individually using a validated LC-MS/MS method. The calibration curves were found to be linear in the range of 0.20–500.0 ng mL −1 for total doxorubicin and in the range of 1.00–1,000 ng mL −1 for free doxorubicin. The free concentrations in plasma were only one sixth to one quarter of the total levels. Liposomal doxorubicin had a longer apparent half-life (>50 h) than the non-targeted drug (
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, K., Zhang, D., Ge, Z., & Qiu, F. (2024). Development and validation of an LC-MS/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer. Acta Chromatographica, 36(3), 186-195. https://doi.org/10.1556/1326.2023.01129
Vancouver
Zhang K, Zhang D, Ge Z, Qiu F. Development and validation of an LC-MS/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer. Acta Chromatographica. 2024;36(3):186-195. doi:10.1556/1326.2023.01129
BibTeX
@article{Zhang2024,
author = {Zhang, Keyu and Zhang, Daqing and Ge, Zhicheng and Qiu, Feng},
title = {Development and validation of an LC-MS/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer},
journal = {Acta Chromatographica},
year = {2024},
volume = {36},
number = {3},
pages = {186--195},
doi = {10.1556/1326.2023.01129}
}
EUVIMED